Cramer's lightning round: 'I like Halliburton very much'
π’ Jim Cramer hosts his weekly "Mad Money" lightning round to answer rapid-fire stock questions from viewers.
β οΈ He advises against buying Beam Therapeutics unless investors believe their technology can save lives, noting the stock is heavily shorted with no earnings.
β Cramer suggests skipping Ondas due to heavy losses and a lack of distinctiveness in its autonomous systems compared to competitors.
π’οΈ Halliburton receives strong praise as he describes it as a great stock that performs well in both good and bad oil markets, calling it very inexpensive.
π Snap is rejected by Cramer because he identifies primarily as a growth buyer and finds the company lacks necessary growth trajectory.
π Nokia is named a winner by Cramer, who applauds the company for returning with strong technology despite past struggles.
β½ Cameco Corporation is recommended as a "real" uranium company that stands out from mock companies lacking genuine resources.
π Novo Nordisk receives a negative outlook from Cramer, who suggests investors in that sector would be better off buying Johnson & Johnson instead.
ποΈ Harley-Davidson is criticized by Cramer for having terrific technology but terrible earnings, leading him to refuse recommending the non-growth stock.
- Jim Cramer states he likes Halliburton very much, highlighting its ability to perform well in both good and bad oil markets.
- According to Cramer, Halliburton continues to be considered a very inexpensive stock despite its strong market performance.
- Halliburton stock has been described as 'awful' in terms of performance compared to growth-focused peers.
- The article notes that Halliburton is a target of heavy short interest, which often correlates with poor market sentiment and lack of earnings support.